Table 3.
Univariate and multivariable associations between adolescent characteristics and TB treatment unfavorable outcome
Characteristic | Univariate logistic model | Multivariate logistic model | ||
---|---|---|---|---|
OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | |
Age (years) | ||||
10–14 | Reference | – | – | – |
15–16 | 0.63 (0.33–1.21) | 0.166 | 0.54 (0.26–1.10) | 0.091 |
17–18 | 1.25 (0.72–2.14) | 0.425 | 1.20 (0.65–2.21) | 0.552 |
Type of TB | ||||
New case | Reference | – | – | – |
Retreatment | 4.38 (2.37–8.08) | < 0.001 | 4.51 (2.23–9.17) | < 0.001 |
Residence area/districts | ||||
2.0 | Reference | – | – | – |
3.1 | 4.02 (1.85–8.72) | < 0.001 | 4.11 (1.79–9.46) | < 0.001 |
3.3 | 4.82 (2.14–10.87) | < 0.001 | 5.35 (2.20–13.03) | < 0.001 |
Other | 2.05 (0.97–4.33) | < 0.059 | 1.77 (0.81–3.87) | 1.159 |
TB–HIV coinfection | ||||
HIV negative | Reference | – | – | – |
HIV positive | 11.69 (5.21–26.24) | < 0.001 | 10.15 (4.15–25.34) | < 0.001 |
Not performed/missing data | 1.34 (0.77–2.35) | 0.301 | 1.02 (0.54–1.89) | 0.970 |
Extreme vulnerability | ||||
No | Reference | – | – | – |
Yes | 3.31 (1.99–5.51) | < 0.001 | 3.01 (1.70–5.33) | < 0.001 |
Direct observed treatment | ||||
No | Reference | – | – | – |
Yes | 0.76 (0.46–1.26) | 0.291 | 1.10 (0.61–1.97) | 0.749 |
Missing data | 1.55 (0.88–2.75) | 0.129 | 2.48 (1.31–4.96) | 0.006 |
Gender | ||||
Female | Reference | – | – | – |
Male | 0.70 (0.47–1.05) | 0.086 | – | – |
TB form | ||||
Pulmonary | Reference | – | – | – |
Pulmonary + extrapulmonary | 0.62 (2.74–1.40) | 0.25 | – | – |
Homeless | ||||
No | Reference | – | – | – |
Yes | 9.88 (2.82–34.45) | < 0.001 | – | – |
Inmates | ||||
No | Reference | – | – | – |
Yes | 1.02 (0.22–4.77) | 0.607 | – | – |
Illicit drug use | ||||
No | Reference | – | – | – |
Yes | 4.44 (2.47–7.97) | < 0.001 | – | – |
Alcohol abuse | ||||
No | Reference | – | – | – |
Yes | 5.7 (1.80–18.02) | 0.005 | – | – |
Comorbidities | ||||
No | Reference | – | – | – |
Yes | 3.66 (0.49–27.65) | 0.208 | – | – |
Tobacco use | ||||
No | Reference | – | – | – |
Yes | 2.44 (1.12–5.29) | 0.028 | – | – |
Xpert testing | ||||
Yes | Reference | – | – | – |
No | 0.73 (0.63–1.39) | 0.735 | – | – |
Xpert testing result | ||||
RIF sensitive | Reference | – | – | – |
RIF resistant | 2.06 (0.38–11.30) | 0.404 | – | – |
Baseline drug susceptibility testing performed | ||||
Yes | Reference | – | – | – |
No | 1.25 (0.82–1.92) | 0.291 | – | – |
OR = odds ratio; RIF = rifampicin; TB = tuberculosis.